Multimodal Imaging Market Expected to Reach $6 Billion by 2030 with Steady Growth

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Multimodal Imaging Market During The Forecast Period 2026–2030?

The multimodal imaging market has shown significant growth in recent years. Projections indicate a rise from $4.32 billion in 2025 to $4.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. Historically, this expansion has been driven by factors such as the advancement of diagnostic imaging, an increase in cancer screening programs, the development of hospital imaging infrastructure, improvements in detector technology, and elevated demand for clinical imaging.

The multimodal imaging market size is anticipated to experience substantial expansion in the upcoming years. It is forecast to grow to $6 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.8%. This expansion during the projection period can be attributed to several factors, including the increasing demand for precision diagnostics, the growing burden of chronic diseases, the embrace of AI imaging analytics, the evolution of hybrid imaging systems, and the broadening of imaging as a service. Noteworthy trends for the forecast period comprise hybrid PET-MR imaging systems, integrated multi-modality diagnostics, AI-assisted image fusion, cloud-based imaging analytics, and advanced multimodal visualization software.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33234&type=smp

Which Major Factors Are Driving The Expansion Of The Multimodal Imaging Market?

The escalating demand for prompt and precise disease identification is anticipated to fuel the expansion of the multimodal imaging market. Early and accurate disease diagnosis refers to the process of detecting illnesses at an initial stage with high precision using medical data and advanced technologies, facilitating timely treatment and better patient outcomes. The increased emphasis on early and accurate disease diagnosis stems from individuals seeking quick and exact detection of diseases for improved treatment and results, enabling healthcare professionals to identify health issues considerably sooner than before. Multimodal imaging supports early and accurate disease diagnosis by allowing the integration of various medical imaging techniques to pinpoint diseases with greater precision. For instance, in October 2024, the National Health Service England, a UK-based public body, reported that based on Rapid Cancer Registration Data, early diagnosis rates by March 2024 were 2.4% points above the pre-pandemic level and 0.8% points higher than the previous year. Consequently, the growing demand for early and accurate disease diagnosis is a key driver for the growth of the multimodal imaging market.

What Market Segments Are Evaluated Within The Multimodal Imaging Market?

The multimodal imaging market covered in this report is segmented –

1) By Product: Multimodal Imaging Equipment; Reagents; Software

2) By Technology: Positron Emission Tomography (PET) Or Computed Tomography (CT) Systems; Single Photon Emission Computed Tomography Or Computed Tomography (CT) Systems; Positron Emission Tomography (PET) Or Magnetic Resonance (MR) Systems; Other Technologies

3) By Application: Oncology; Cardiology; Neurology; Ophthalmology; Musculoskeletal Disorders; Other Applications

4) By End-User: Hospitals; Diagnostic Imaging Centers; Other End-Users

Subsegments:

1) By Multimodal Imaging Equipment: Magnetic Resonance Imaging Scanner; Computed Tomography Scanner; Positron Emission Tomography Scanner; Single Photon Emission Computed Tomography Scanner; Optical Imaging System; Photoacoustic Imaging System; Hybrid Imaging System

2) By Reagents: Contrast Agents; Radiopharmaceuticals; Fluorescent Dyes; Molecular Probes

3) By Software: Image Processing Software; Analysis And Visualization Software; Data Management Software; Workflow And Reporting Software

What Industry Trends Are Redefining The Multimodal Imaging Market?

Leading companies within the multimodal imaging market are concentrating on advancements in artificial intelligence and machine learning for analyzing and interpreting images, particularly AI-assisted image segmentation, which allows for the automated recognition of anatomical structures and areas of interest across diverse imaging methods. AI-assisted image segmentation utilizes artificial intelligence algorithms to automatically partition images into relevant regions, a task historically requiring manual tracing by human specialists. For example, in September 2025, Revvity, Inc., a US-based firm specializing in preclinical imaging solutions, introduced Living Image Synergy AI multimodal analysis software. This software delivers a cohesive, AI-powered platform for the fluid analysis of in vivo imaging data across optical, microCT, ultrasound, and other modalities. It diminishes data discrepancies by centralizing workflows and removing the need for multiple independent tools. Moreover, it integrates advanced AI algorithms to automate image segmentation and region-of-interest quantification, thereby enhancing precision and consistency. Intuitive co-registration and automated procedures additionally reduce manual effort and analysis duration.

Which Global Companies Are Actively Competing In The Multimodal Imaging Market?

Major companies operating in the multimodal imaging market are Samsung Medison Co. Ltd., Analogic Corporation, Alcon Inc., Hologic Inc., Sofie Biosciences Inc., ShanghAI United Imaging Healthcare Co. Ltd., Topcon Corporation, Agfa-Gevaert Group, Heidelberg Engineering GmbH, Optos plc, RefleXion Medical Inc., Neusoft Corporation, Infraredx Inc., MinFound Medical Systems Co. Ltd., Neusoft Medical Systems Co. Ltd., Spectrum Dynamics Medical LLC, Konica Minolta Healthcare Americas Inc., Esaote S.p.A., MR Solutions Ltd., MILabs B.V., NIDEK Co. Ltd., Kowa Company Ltd., and Positron Corporation.

Read the full multimodal imaging market report here:

https://www.thebusinessresearchcompany.com/report/multimodal-imaging-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Multimodal Imaging Market?

North America was the largest region in the multimodal imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multimodal imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Multimodal Imaging Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33234&type=smp

Browse Through More Reports Similar to the Global Multimodal Imaging Market 2026, By The Business Research Company

Multimodal Ai Market Report 2026

https://www.thebusinessresearchcompany.com/report/multimodal-ai-global-market-report

Generative Ai In Media And Entertainment Market Report 2026

https://www.thebusinessresearchcompany.com/report/generative-ai-in-media-and-entertainment-global-market-report

Generative Ai In Media Market Report 2026

https://www.thebusinessresearchcompany.com/report/generative-ai-in-media-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795